| Type | Description |
|---|---|
| Definition | galectin 1 |
| Date | Results | Publications |
|---|---|---|
| 2019-08-17 11:15:00 | Dysregulated Gal-1 and Ca(V)1.2 alternative exon 9* might be attributed to the pathological processes of cardiac hypertrophy, and provides a potential anti-hypertrophic target in the heart. | 30463690 |
| 2018-03-24 10:11:00 | Stress-induced Gal-1 immediately accumulates in the spleen and thymus, and may modulate the immune response through apoptosis by binding to CD45(+) lymphocytes in immune organs following physiological and/or psychological stress. | 27573167 |
| 2016-08-13 11:47:00 | GAL1 has an essential role in HFD-induced obesity development. From a clinical viewpoint, pharmaceutical targeting of GAL1 using TDG and other inhibitor compounds would be a novel therapeutic approach for the treatment of obesity | 25920776 |
| 2016-06-28 11:32:00 | Galectin-1 protein is protective on in vivo and in vitro models of ocular inflammation. | 26392742 |
| 2012-02-25 10:58:00 | Galectin-1-binding glycoforms of haptoglobin | 22028908 |
| Type | IDs |
|---|---|
| Gene |
UniProtKB-ID:
LEG1_RAT
UniprotKB:
P11762
UniParc:
UPI000004E611
EMBL:
M19036,
BC058476
Ensembl:
ENSRNOG00000009884
KO:
rno:56646
|
| Nucleutide sequences |
EMBL-CDS:
AAH58476.1,
AAA40822.1
Ensembl_TRS:
ENSRNOT00000013538
|
| Protein sequencees |
Ensembl_PRO:
ENSRNOP00000013538
RefSeq:
NP_063969.1
|
| Others |
UniRef100:
UniRef100_P11762
UniRef90:
UniRef90_P16045
UniRef50:
UniRef50_P16045
UniGene:
Rn.57
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员